Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SABS

SAB Biotherapeutics (SABS)

SAB Biotherapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SABS
DateTimeSourceHeadlineSymbolCompany
06/05/202421:15GlobeNewswire Inc.SAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of DirectorsNASDAQ:SABSSAB Biotherapeutics Inc
16/04/202421:15GlobeNewswire Inc.SAB Biotherapeutics Provides SAB-142 Trial UpdateNASDAQ:SABSSAB Biotherapeutics Inc
08/04/202421:15GlobeNewswire Inc.SAB Biotherapeutics to Present at INNODIA Annual MeetingNASDAQ:SABSSAB Biotherapeutics Inc
04/04/202422:15GlobeNewswire Inc.SAB Biotherapeutics to Present at the Needham Virtual Healthcare ConferenceNASDAQ:SABSSAB Biotherapeutics Inc
29/03/202422:15GlobeNewswire Inc.SAB Biotherapeutics Reports Full Year 2023 Operating and Financial ResultsNASDAQ:SABSSAB Biotherapeutics Inc
26/03/202401:15GlobeNewswire Inc.SAB Biotherapeutics Announces Clinical Partnership with Naval Medical Research Center to Advance Potential Influenza TreatmentNASDAQ:SABSSAB Biotherapeutics Inc
09/03/202408:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SABSSAB Biotherapeutics Inc
24/02/202408:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SABSSAB Biotherapeutics Inc
24/02/202408:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SABSSAB Biotherapeutics Inc
24/02/202400:00GlobeNewswire Inc.SAB Biotherapeutics to Present at the BIO CEO & Investor ConferenceNASDAQ:SABSSAB Biotherapeutics Inc
09/02/202400:00GlobeNewswire Inc.SAB Biotherapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:SABSSAB Biotherapeutics Inc
02/02/202423:53Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SABSSAB Biotherapeutics Inc
02/02/202423:30GlobeNewswire Inc.SAB Biotherapeutics Announces Executive Leadership ChangeNASDAQ:SABSSAB Biotherapeutics Inc
27/01/202408:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SABSSAB Biotherapeutics Inc
27/01/202408:00Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SABSSAB Biotherapeutics Inc
26/01/202409:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SABSSAB Biotherapeutics Inc
24/01/202409:58GlobeNewswire Inc.SAB Biotherapeutics Regains Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:SABSSAB Biotherapeutics Inc
20/01/202408:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SABSSAB Biotherapeutics Inc
04/01/202401:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SABSSAB Biotherapeutics Inc
03/01/202408:30GlobeNewswire Inc.SAB Biotherapeutics Announces 1-for-10 Reverse Stock SplitNASDAQ:SABSSAB Biotherapeutics Inc
19/12/202301:34Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SABSSAB Biotherapeutics Inc
09/12/202309:26Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:SABSSAB Biotherapeutics Inc
01/12/202309:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SABSSAB Biotherapeutics Inc
29/11/202323:40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SABSSAB Biotherapeutics Inc
29/11/202323:30GlobeNewswire Inc.SAB Biotherapeutics Announces Commencement of the HUMAN Phase 1 Clinical Trial with SAB-142, a Potential Disease-Modifying Treatment for Type 1 DiabetesNASDAQ:SABSSAB Biotherapeutics Inc
29/11/202316:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SABSSAB Biotherapeutics Inc
29/11/202308:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SABSSAB Biotherapeutics Inc
29/11/202308:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SABSSAB Biotherapeutics Inc
23/11/202308:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SABSSAB Biotherapeutics Inc
21/11/202309:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SABSSAB Biotherapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:SABS